Table of Contents
Chemotherapy Research and Practice
Volume 2012, Article ID 817297, 9 pages
http://dx.doi.org/10.1155/2012/817297
Review Article

Mechanisms of Resistance to Epidermal Growth Factor Receptor Inhibitors and Novel Therapeutic Strategies to Overcome Resistance in NSCLC Patients

Division of Hematology/Oncology, Department of Medicine, USCF Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, CA 94158, USA

Received 12 April 2012; Accepted 30 July 2012

Academic Editor: Nabil F. Saba

Copyright © 2012 Luping Lin and Trever G. Bivona. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

How to Cite this Article

Luping Lin and Trever G. Bivona, “Mechanisms of Resistance to Epidermal Growth Factor Receptor Inhibitors and Novel Therapeutic Strategies to Overcome Resistance in NSCLC Patients,” Chemotherapy Research and Practice, vol. 2012, Article ID 817297, 9 pages, 2012. https://doi.org/10.1155/2012/817297.